Cargando…
E2F1 inhibits cellular senescence and promotes oxaliplatin resistance in colorectal cancer
BACKGROUND: Doctors have always been overwhelmed by tumor drug resistance because it is a major challenge in the clinical treatment of tumors. Cellular senescence has a strong relationship with the development of tumor drug resistance. Herein, we aimed to explore new regulatory factors involved in t...
Autores principales: | Gao, Haiyang, Zhou, Fangyuan, Li, Runze, Yuan, Jiao, Ye, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009566/ https://www.ncbi.nlm.nih.gov/pubmed/36923082 http://dx.doi.org/10.21037/atm-22-4054 |
Ejemplares similares
-
Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer
por: Zhou, Fangyuan, et al.
Publicado: (2023) -
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021) -
Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
por: Ning, Tao, et al.
Publicado: (2021) -
Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance
por: Zhang, Ye, et al.
Publicado: (2017) -
Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer
por: Park, Sun Young, et al.
Publicado: (2022)